A Disintegrin and Metalloprotease with Thrombospondin Motif 2 May Contribute to Cirrhosis in Humans through the Transforming Growth Factor-β/SMAD Pathway
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: We aimed to investigate the correlation between a disintegrin and metalloprotease with thrombospondin motif 2 (ADAMTS-2) and transforming growth factor-β1 (TGF-β1) in clinical human cirrhotic tissues. Methods:The liver tissues of 24 patients (16 cases with cirrhotic portal hypertension as the cirrhosis group and eight cases with healthy livers as the normal group) were collected. Immunohistochemistry and Western blots were performed to evaluate the protein expression levels of ADAMTS-2 and TGF-β1. Western blots for other key mediators of cirrhotic progression, including SMAD2, SMAD3, TGF-β receptor II (TGFβRII), matrix metalloproteinases 2 (MMP2), and tissue inhibitor of matrix metalloproteinases 2 (TIMP2), were also performed. Results: Cirrhotic tissues showed higher percentages of collagen. The protein expression levels of ADAMTS-2and TGF-β1 were significantly higher in the cirrhotic group as compared to the matched normal group (p<0.05), and there was a positive correlation between these two proteins (r=0.862, p<0.01). The protein expressions of MMP2, TIMP2,and TGFβRII, as well as the phosphorylated forms of SMAD2and SMAD3, were significant higher in the cirrhotic group (p<0.01 or p<0.05). Conclusions: These findings suggested that ADAMTS-2 and TGF-β1 may play important roles in the pathogenesis of human cirrhosis; specifically, TGF-β1 may induce the expression of ADAMTS-2 through the TGFβ/SMAD pathway.
Abstract
Background/Aims: We aimed to investigate the correlation between a disintegrin and metalloprotease with thrombospondin motif 2 (ADAMTS-2) and transforming growth factor-β1 (TGF-β1) in clinical human cirrhotic tissues. Methods:The liver tissues of 24 patients (16 cases with cirrhotic portal hypertension as the cirrhosis group and eight cases with healthy livers as the normal group) were collected. Immunohistochemistry and Western blots were performed to evaluate the protein expression levels of ADAMTS-2 and TGF-β1. Western blots for other key mediators of cirrhotic progression, including SMAD2, SMAD3, TGF-β receptor II (TGFβRII), matrix metalloproteinases 2 (MMP2), and tissue inhibitor of matrix metalloproteinases 2 (TIMP2), were also performed. Results: Cirrhotic tissues showed higher percentages of collagen. The protein expression levels of ADAMTS-2and TGF-β1 were significantly higher in the cirrhotic group as compared to the matched normal group (p<0.05), and there was a positive correlation between these two proteins (r=0.862, p<0.01). The protein expressions of MMP2, TIMP2,and TGFβRII, as well as the phosphorylated forms of SMAD2and SMAD3, were significant higher in the cirrhotic group (p<0.01 or p<0.05). Conclusions: These findings suggested that ADAMTS-2 and TGF-β1 may play important roles in the pathogenesis of human cirrhosis; specifically, TGF-β1 may induce the expression of ADAMTS-2 through the TGFβ/SMAD pathway.
참고문헌 (16)
- Kirmaz C, "Serum transforming growth factor-beta1 (TGF-beta1) in patients with cirrhosis, chronic hepatitis B and chronic hepatitis C", Eur Cytokine Netw, 15, pp.112~116 (2004)
- Li HJ, "Effect of transforming growth factor-β1 on thrombospondin-1 in hepatic fibrosis", Chin J Exp Surg, 27, pp.1674~1676 (2010)
- Inagaki Y, "Emerging insights into transforming growth factor beta Smad signal in hepatic fibrogenesis", Gut, 56, pp.284~292 (2007)
- Iredale JP, "Hepatic stellate cell behavior during resolution of liver injury", Semin Liver Dis, 21, pp.427~436 (2001)
- Colige A, "Domains and maturation processes that regulate the activity of ADAMTS-2, a metalloproteinase cleaving the aminopropeptide of fibrillar procollagens types I-III and V", J Biol Chem, 280, pp.34397~34408 (2005)
- Yung S, "Elevated glucose induction of thrombospondin-1 up-regulates fibronectin synthesis in proximal renal tubular epithelial cells through TGF-beta1 dependent and TGF-beta1 independent pathways", Nephrol Dial Transplant, 21, pp.1504~1513 (2006)
- Brenner DA, "Type I collagen gene regulation and the molecular pathogenesis of cirrhosis", Am J Physiol, 264(4 Pt 1), pp.G589~G595 (1993)
- Kesteloot F, "ADAM metallopeptidase with thrombospondin type 1 motif 2 inactivation reduces the extent and stability of carbon tetrachloride-induced hepatic fibrosis in mice", Hepatology, 46, pp.1620~1631 (2007)
- Nicholson AC, "Functional evolution of ADAMTS genes: evidence from analyses of phylogeny and gene organization", BMC Evol Biol, 5, pp.11~ (2005)
- Wang WM, "Transforming growth factor-beta induces secretion of activated ADAMTS-2. A procollagen III N-proteinase", J Biol Chem, 278, pp.19549~19557 (2003)
- Schwettmann L, "Hepatic expression of A disintegrin and metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases", J Hepatol, 49, pp.243~250 (2008)
- Moss ML, "Therapeutic benefits from targeting of ADAM family members", Biochemistry, 43, pp.7227~7235 (2004)
- Le Goff C, "The ADAMTS(L) family and human genetic disorders", Hum Mol Genet, 20(R2), pp.R163~R167 (2011)
- Kato J, "Transforming growth factor-beta-induced stimulation of formation of collagen fiber network and anti-fibrotic effect of taurine in an in vitro model of hepatic fibrosis", Hepatol Res, 30, pp.34~41 (2004)
- Nakano S, "Bezafibrate prevents hepatic stellate cell activation and fibrogenesis in a murine steatohepatitis model, and suppresses fibrogenic response induced by transforming growth factor-beta1 in a cultured stellate cell line", Hepatol Res, 38, pp.1026~1039 (2008)
- Kondou H, "A blocking peptide for transforming growth factor-beta1 activation prevents hepatic fibrosis in vivo", J Hepatol, 39, pp.742~748 (2003)